Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
-
Alpha Modus Agrees to Preferred Stock Exchange to Eliminate ~$41 Million in Mezzanine Equity, Strengthening Balance Sheet, and Fully Aligning Insider Interests
-
Real Career Mode FC Launches Fan-Driven Football Club Ownership Model
-
LIXTE Biotechnology Holdings Provides Corporate Update
-
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
-
Nuvini Group Unveils New Leadership Incentive Plan, Underscoring Commitment to Shareholders
-
Optex Systems to Present at the 2025 Gateway Conference on September 4
-
Aditude Appoints Anthony Gonsalves as First Chief Revenue Officer
-
Hepsiburada Announces Ordinary General Assembly Meeting for Financial Year 2024
-
Schouw & Co. share buy-back programme, week 33 2025
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
JDE Peet’s share buyback periodic update August 18, 2025
-
Enlivex Announces Positive Topline Data From Multi-Country, Randomized, Controlled, Phase I/II Trial Evaluating Allocetra in Patients With Moderate-To-Severe Knee Osteoarthritis
-
Conversion of Senior Unsecured Convertible Debentures Due August 30, 2027
-
Alert for Long-Term Shareholders of Flywire Corporation (NASDAQ: FLYW); Ibotta, Inc. (NYSE: IBTA); iRobot Corporation (NASDAQ: IRBT); and SelectQuote, Inc. (NYSE: SLQT); Grabar Law Office is Investiga
-
Holding(s) in Company
-
ParaZero Receives Order from a Defense Entity for its Counter Drone Technology
-
Auction result of Treasury Bills - RIKV 25 1119 - RIKV 26 0318
-
Mattr Appoints New Director
-
180 Degree Capital Corp. and Mount Logan Capital Inc. Announce Revised Terms of Business Combination in Response to Constructive Conversations with Shareholders
-
Aptose Reports Early Data Demonstrating Tuspetinib Improves Standard of Care Treatment Across Diverse Populations of Newly Diagnosed AML in Phase 1/2 TUSCANY Trial
-
Promising Outcome From Collaboration With Dundee Sustainable Technologies
-
Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases
-
PDD Holdings to Report Second Quarter 2025 Unaudited Financial Results on August 25, 2025
-
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
-
DallasNews Corporation Files Definitive Proxy Statement and Issues Letter to Shareholders
-
OneMedNet initiates new Subscription Revenue model in partnership with Circle CVI
-
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
-
SL Green Realty Corp. Announces Common Stock Dividend
-
Allied Provides Development Update
-
Hisummer Launches Two Flameless Candle Warmer Lamps for Fall & Winter 2025 Décor and Gifting
-
Hisummer Launches Two Flameless Candle Warmer Lamps for Fall & Winter 2025 Décor and Gifting
-
Bitdeer Reports Unaudited Financial Results for the Second Quarter of 2025
-
Howard Hughes Holdings to Host Annual Shareholder Meeting on September 30 at 9:00 a.m. at The Pershing Square Signature Center in New York City
-
Coppernico Advances New Copper-Gold Alteration Systems at Sombrero
-
Serve Robotics Acquires Vayu Robotics to Pioneer AI Foundation Model-Based Autonomy for Last-Mile Delivery
-
RTDNA Awards a Record 10 National Edward R. Murrow Awards to Gray Media Stations – the Most of Any Broadcaster
-
Unicycive Therapeutics Granted New U.S. Patent for UNI-494 to Treat Chronic Kidney Disease
-
TeraWulf Inc. Announces Proposed Private Offering of $400 Million of Convertible Notes
-
Cielo Announces Closing of Second and Final Tranche of Unit Offering
-
Apollo Silver Engages CDMG for Marketing Services
-
Colonel (Ret.) Derek Bird Joins Kägwerks, a Codan Company, as Director of Program Management
-
FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation
-
ASDSA Adds Additional Skin Cancer Prevention Methods to Its Successful SUNucate Model Legislation
-
BioXcel Therapeutics Announces Positive FDA Pre-sNDA Meeting Comments for sNDA Submission for BXCL501 in Agitation Associated with Bipolar Disorders or Schizophrenia
-
Bath & Body Works Debuts New Disney Villains-Inspired Fragrance Collection
-
TeraWulf Announces Fluidstack Expansion with 160 MW CB-5 Lease at Lake Mariner
-
Trident Announces Strategic Investment in Web 3.0 E-Commerce Firm Tongxin Innovation Limited
-
Talisker Receives Assay Results from 1060 Level Lateral Development at the Mustang Mine
-
Tintina Mines Completes Drilling Campaign and Reports Key Geometallurgical Advances to Support 2025 PEA for Domeyko Sulfuros Project
